Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.3618
H.R.3618: Orphan Drug Fairness Act
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Sept. 25, 2015
- Latest Major Action Oct. 2, 2015
Bill Sponsor
Bill Cosponsors
7 (2 Democrats, 5 Republicans)
Bill Summary
Orphan Drug Fairness Act This bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. This Act is effective as if included in PPACA.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Oct. 2, 2015 |
Referred to the Subcommittee on Health.
|
| Sept. 25, 2015 |
Referred to House Energy and Commerce
|
| Sept. 25, 2015 |
Referred to House Ways and Means
|
| Sept. 25, 2015 |
Introduced in the House by Leonard Lance (R-N.J.) |